About this trial
Sensorimotor function of the upper limb is commonly impaired after stroke, even in the chronic phase (\>6 months post-stroke). Nevertheless, good sensorimotor function is needed for daily life functioning. Sensorimotor function can be divided into three components: exteroception, proprioception and sensory processing. It is important that those three components will each be addressed in the upper limb rehabilitation. Unfortunately, there is still no optimal therapy to address sensory processing. Therefore, the investigators developed an intensive sensorimotor robot-based rehabilitation paradigm (called ROBUST) with focus on sensory processing. As a first step, the investigators did a pilot study (S69003) including 10 persons with chronic stroke to investigate the potential effectiveness and feasibility of this novel rehabilitation. The median change score of motor, sensory and sensorimotor assessments was exceeding the minimal clinical important difference (MCID), and the total amount of therapy was feasible as well. The investigated protocols to measure potential changes in brain function (activity and connectivity) and structure accompanying the novel therapy appeared feasible as well. Based on this first pilot study, the investigators finalized the protocol for this RCT to investigate the effectiveness of the ROBUST intervention.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Written informed consent must be obtained prior to any screening procedures;
A first-ever unilateral, supra-tentorial stroke, as defined by WHO (rapidly developing clinical signs of focal (or global) disturbance of cerebral function, with symptoms lasting 24 hours or longer or leading to death, with no apparent cause other than vascular origin);
≥18 and ≤85 years old;
Being a Dutch speaker;
Disqualifiers
Having musculoskeletal and/or other neurological disorders impacting care or prognosis;
Having severe communication or cognitive deficits that interfere with the protocol;
Having severe spasticity (cannot handle Kinarm robot);
Any disorder, which in the investigator's opinion might jeopardise participant's safety or compliance with the CIP;
Trial design
Parallel
Treatments tested in this trial
ROBUST
BehavioralDuring a 5-week intervention, participants in the stroke experimental group get 48 hours additional sensorimotor upper limb training. They will come 2-3 times per week to Leuven for a therapy session of two hours. During these therapy sessions, they receive one hour robot-based therapy (Kinarm therapy) and one hour transfer package training with a therapist. Additionally, they follow 4-5 times a week a 1-hour home program. This intervention can be distinguished from others since it integrates both motor and sensory function, with focus on sensory processing. It combines robot-based therapy, a transfer package to daily activities, and a home program.
Kinarm therapy
BehavioralDuring a 5-week intervention, participants in the stroke control group and the healthy control group get 12 hours additional Kinarm therapy (one part of the ROBUST intervention). They will come 2-3 times per week to Leuven for a one-hour therapy session. This robotic intervention can be distinguished from others since it integrates both motor and sensory function, with focus on sensory processing.
Treatment groups
Trial outcomes
Primary outcomes
Action Research Arm Test
Clinical assessment of motor activity performance on an ordinal scale ranging from 0 to 57, with higher scores meaning better performance.
Secondary outcomes
Sensorimotor Action Research Arm Test
Clinical assessment of sensorimotor activity performance on an ordinal scale ranging from 0 to 57, with higher scores meaning better performance.
Fugl-Meyer Assessment for the upper extremity
Clinical assessment of motor function on an ordinal scale ranging from 0 to 66, with higher scores meaning better performance.
Tactile Discrimination Test
Clinical assessment of sensory processing with an area under the curve based scoring system ranging from 0-100%, with higher scores meaning better performance.
Stroke Impact Scale
A self-report questionnaire that evaluates disability and health-related quality of life after stroke. Each category ranges from 0-100. A higher score indicates less disability and better quality of life.
Other outcomes
Oxford Cognitive Screen
A domain-specific cognitive screening tool. The domains assessed are Language, Praxis, Number, Memory, Spatial and Controlled Attention. The following tasks are included: Picture Naming (range: 0-4), Semantics (range: 0-3), Orientation (range: 0-4), Visual Field (range: 0-4), Sentence Reading (range: 0-15), Number Writing (range: 0-3), Calculation (range: 0-4), Broken Hearts Test (range: 0-50), Imitation (range: 0-12), Verbal Recall \& Recognition (range: 0-4), Episodic recognition (range: 0-4) and Executive task (perfect outcome = -1). Higher scores mean better cognitive performance, except for the Executive task.
Motivation for Rehabilitation Scale
A questionnaire investigating the motivation of the patient for following rehabilitation ranging from 0 to 119 points. A higher score means a higher motivation.
Patient Experience Questionnaire
A study-specific questionnaire to gather feedback regarding the ROBUST intervention. Included questions where multiple-choice questions, questions ranging from fully agree to fully disagree, and open questions.
This trial is not recruiting at the moment. You can still explore other options: